American Journal of Pain Management Vol17 No1 - Jan 1 07
Geoffrey T. Desmoulin, BSc, MSc, and Aslam H. Khan, DC

Abstract: Uncontrolled pain is occurring in epidemic proportions. Approximately 45% of Americans seek care for chronic pain at some point in their lives, and over one-third of the world’s population suffers from chronic or recurrent pain. Pain costs the American public in excess of $100 billion annually, and spinal pain is a chief complaint. This initial component of a two-part series, presents a review of the pathophysiologic mechanisms of spinal pain. The second installment will present the mechanistic theory on which a novel treatment strategy for spinal pain is based.

Introduction: Neuropathic pain following central nervous system (CNS) compromise is not as well defined as general chronic pain in that there are few definitive data on the number of patients who suffer various neuropathic disorders. Without clear diagnostic data and evidence based effective treatments, it is difficult to estimate the cost of neuropathic pain on the health care system. The development of successful pain treatments that address the problem is predicated on understanding the mechanisms that generate and maintain chronic pain.

Desmoulin G. T., Yasin N. I., Chen D. W.
Clinical Journal of Pain. 2007 23(7):576-585)

Objective: Demonstrate initial results using Khan Kinetic Treatment [KKT™] as a chronic neck pain treatment option.

Methods: A self-reported functional assessment, neck pain questionnaire and pain medication dose were used as outcome measures for matched subjects randomly split into two groups [“treatment” and “control”]. The “treatment” group underwent a treatment period consisting of several individual KKT™ treatments over a few weeks period while the “control” group continued conventional treatment. A paired t-test analyzed the functional assessment scores and a two group by two neck pain score [neutral or positive] chi-squared test was used for the neck pain questionnaires. Pain medication dose analysis consisted of a two group by two pain medication dose outcome [same or reduced] chi-squared test.

Results and Conclusion: Compared to a control group, the treatment group lowered both their self-recorded neck pain scores [P=0.012] and pain medication dose [P=0.048]. Early results show that KKT™ is an effective treatment for chronic neck pain and contributes to the reduction of pain relieving medication.

Journal of Musculoskeletal Pain, 2007 15(3):91-102)
Desmoulin G. T., Yasin N. I., Chen D. W.

Objectives: Demonstrate initial results using Khan Kinetic Treatment [KKT™] as a low back pain [LBP] treatment option.

Methods: A self-reported functional assessment, LBP questionnaire, and pain medication dose were used as the outcome measures for matched subjects randomly split into two groups [treatment and control]. The treatment group underwent a treatment period consisting of several individual KKT™ treatments over a few weeks period, while the control group continued conventional treatment. A paired t-test analyzed the functional assessment scores and a two group by two LBP score [positive or non-positive] McNemar’s test was used for the LBP questionnaires. Pain medication dose analysis consisted of a two group by two pain medication dose outcome [same or reduced] McNemar’s test.

Results and Conclusion: Compared to a control group, the treatment group lowered both their self-recorded LBP scores [P